Immuneering (IMRX) Other Non-Current Assets (2020 - 2026)

Immuneering's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $278129.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 65.7% year-over-year to $278129.0 in Q1 2026; TTM through Mar 2026 was $278129.0, a 65.7% decrease from a year earlier, with the FY2025 full-year figure at $283562.0, down 78.12% from the prior year.
• Other Non-Current Assets slipped to $278129.0 in Q1 2026 per IMRX's latest filing, from $283562.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $1.3 million in Q4 2024 and bottomed at $89579.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $743703.0 (2022), against an average of $753538.4.
• Biggest YoY gain for Other Non-Current Assets was 5044.02% in 2022; the steepest drop was 90.67% in 2022.
• Year by year, Other Non-Current Assets stood at $743703.0 in 2022, then jumped by 39.09% to $1.0 million in 2023, then climbed by 25.26% to $1.3 million in 2024, then sank by 78.12% to $283562.0 in 2025, then retreated by 1.92% to $278129.0 in 2026.
• Per Business Quant, the three latest IMRX Other Non-Current Assets figures stand at $278129.0 (Q1 2026), $283562.0 (Q4 2025), and $631297.0 (Q3 2025).